Device Family & Worst-Case Representative Device Justification Pack
Help medical-device teams define a defensible device-family working boundary and document which final-finished device or devices represent each biological-evaluation question, with traceable facts, evidence, limitations, named review, and change triggers.
Package at a glance
11 ZIP entries
The current customer archive passed exact-inventory, checksum, and deterministic-rebuild QA.
18 workbook sheets
A fail-closed working system with sample content kept separate.
3-page Quick Start
A concise route through the files, controls, and escalation points.
23 official sources
Source status, limitations, retrieval dates, and recheck triggers.
A traceable working record—not a shortcut to a conclusion
Variant boundaries, question-specific challenge dimensions, representative-device decisions, evidence applicability, and lifecycle change control
Controlled Variant Boundary
A controlled variant inventory tied to final-finished configurations, intended use, contact route, cumulative duration, population, manufacturing state, sterilization, packaging, and shelf-life state.
Question-Specific Challenge Logic
A family-boundary hypothesis that records shared characteristics, meaningful differences, exclusions, evidence, uncertainty, and the precise decision for which grouping is proposed.
Representative-Device Plan
Question-specific challenge dimensions instead of a single ranking score or a universal worst-case device. Use the free selection starter when you first need to frame one question and up to four candidates.
Evidence and Change Trace
A candidate comparison that can select one device, multiple devices, pooled articles, or no adequate representative, with explicit coverage and limitations.
What the current customer edition contains
The verified v3.0 archive contains 9 buyer payload files plus MANIFEST.csv and SHA-256 checksums. Final document, workbook, visual, and archive-integrity QA are complete.
Quick Start PDF
Set the decision question, stop conditions, and eight-step working sequence.
Complete when: The team knows what grouping and representative decision is being considered, which reviewers are required, and what the pack cannot conclude.
Implementation Guide PDF
Apply the full variant, boundary, challenge-dimension, candidate, evidence, article, jurisdiction, and lifecycle method.
Complete when: A reviewer can reconstruct the facts, question, selected representative or representatives, exclusions, limitations, and change triggers.
Editable Working Templates DOCX
Draft ten controlled narratives and approval records.
Complete when: All blank and fictional fields are replaced with device-specific controlled information.
Operational Workbook XLSX
Control variants, boundaries, contact, material/process, questions, candidates, evidence, articles, risks, changes, red flags, actions, and sources.
Complete when: Every seeded control is assessed, open actions remain visible, and named scientific decisions are recorded outside the formulas.
Source Status and Release Notes PDF
Verify current ISO, FDA, EU, MDCG, and India source status used by the candidate.
Complete when: Edition, recognition extent, transition, draft status, legal text date, jurisdiction, and recheck trigger match the intended use.
README, responsible-use terms, source register, manifest, and checksums
Orient the buyer and preserve package identity and integrity.
Complete when: Product ID, version, inventory, hashes, use boundary, and support route agree across the controlled delivery.
Inspect the actual working system
These are direct renders of the current v3.0 workbook prepared as public product views, not marketing mock-ups. Select any image to inspect it at full size.
How the resource is intended to be used
The complete Quick Start and implementation guide are included in the current v3.0 customer edition. This public walkthrough lets a buyer inspect the operating logic and stop conditions before requesting an exact offer.
Decision charter
Freeze the exact decision question, device line, market context, and review roles.
Stop if: The requested conclusion is broad, the final-finished configurations are not controlled, or a required qualified reviewer is missing.
Controlled variant inventory
Build the variant inventory and preserve meaningful differences rather than normalizing them away.
Stop if: A variant, component, supplier, formulation, process, sterilization, package, age state, or use condition is uncertain.
Comparability fact base
Map contact, exposure, material, process, surface, geometry, and final-state characteristics.
Stop if: A contacting path, cumulative duration, degradation product, residue, coating, colorant, joining material, or population difference is unbounded.
Family-boundary record
State a family-boundary hypothesis for one defined purpose and identify exclusions.
Stop if: The grouping is based only on trade name, submission bundling, intended use, or shared base material.
Question matrix
Define the biological question and its relevant challenge dimensions.
Stop if: The team tries to rank devices without stating what biological or evidence question the representative must answer.
Representative-device plan
Compare candidate final-finished devices and select one, several, a pooled set, or no adequate representative.
Stop if: The selected candidate does not bound all relevant differences or a larger geometry is assumed to override a formulation or process change.
Evidence and article trace
Bridge prior evidence and trace the exact proposed article to the controlled device configuration.
Stop if: A prior report, coupon, component, or legacy configuration is used without a complete difference and impact analysis.
Qualified-review package
Reconcile red flags, risk, PMS, jurisdictions, changes, actions, sources, limitations, and approvals.
Stop if: Any terminal conclusion lacks evidence, rationale, reviewer authority, decision ID, date, limitation, or recheck trigger.
Current public authorities behind the working controls
Sources were checked 2026-08-02; next planned portfolio recheck is 2026-11-02. Live status must still be verified at each material decision or submission event.
ISO · ISO 10993-1:2025 catalog record
Published sixth edition in November 2025. Obtain and control a lawful copy; this pack does not reproduce standards text.
FDA · Recognition record 2-313 — ISO 10993-1:2025
Partial recognition entered 2026-05-25 with stated exclusions and cautions. Previous recognition 2-258 transition ends 2029-07-01.
FDA · Recognition record 2-258 — ISO 10993-1:2018 with amendment
Superseded recognition retained only within the transition stated on current FDA records; verify at submission.
FDA · Use of International Standard ISO 10993-1 — final guidance
Final guidance issued September 2023; read with current recognition records and device-specific requirements.
FDA · Component and Device Documentation Examples for Test Articles or Previously Marketed Devices
Generalized documentation examples, not a substitute for device-specific comparison and risk justification.
FDA · Basics of Biocompatibility: Information Needed for Assessment
Current FDA educational resource verified active on the checked date.
What the resource deliberately does not promise
Clear boundaries protect the buyer and make the working records more useful to qualified reviewers.
Clear boundary 1
No legally recognized family designation, universal worst-case ranking, automatic representative-device choice, or test-article authorization.
Clear boundary 2
No automatic endpoint, test, waiver, method, extraction, sample-size, toxicological-acceptability, biological-safety, evidence-equivalence, conformity, submission-readiness, or regulator-acceptance conclusion.
Clear boundary 3
No assumption that the largest device, longest contact, maximum surface area, common intended use, shared material name, platform, trade name, or submission bundling controls every biological question.
Clear boundary 4
No reproduction of ISO standards or replacement for lawfully obtained controlled standards, device-specific requirements, laboratory procedures, and current regulator instructions.
Questions to settle before requesting an offer
Is the current v3.0 edition available?
Yes. The current v3.0 customer edition is released and available by request. Online checkout, payment, customer download, and automatic delivery are not currently enabled. Use Request Exact Offer to receive the controlled offer before deciding whether to pay.
What is included in the current v3.0 edition?
The verified archive contains 11 ZIP entries: 9 buyer payload files plus MANIFEST.csv and SHA-256 checksums. It includes a 3-page Quick Start, 19-page implementation guide, 13-page editable templates, and 18-sheet workbook. Final document, workbook, visual, and archive-integrity QA are complete.
Does the resource provide a completed regulatory or biological conclusion?
No. It provides a traceable working system. Device-specific conclusions, testing decisions, toxicological judgments, and submission decisions require qualified review.
Can I inspect the product before requesting an offer?
Yes. This page shows the complete workflow and real v3.0 product views, while the downloadable 6-page public preview explains the scope, operating logic, included files, and important limits.
How to Select a Worst-Case Representative Device
Compare variants question by question so family coverage is based on relevant exposure and evidence—not on one unsupported “largest device” claim.
Review the workflow now. Request the exact current offer.
No order, payment, customer download, or delivery is created through this page. The controlled offer identifies the exact version, licence, price, update option, policies, and delivery method for your review before any payment decision.